These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32302675)
21. Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene. SoRelle JA; Frame I; Falcon A; Jacob J; Wagenfuehr J; Mitui M; Park JY; Filkins L J Appl Lab Med; 2020 Sep; 5(5):889-896. PubMed ID: 32483586 [TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction. Kim CH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730 [TBL] [Abstract][Full Text] [Related]
23. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Chi X; Yan R; Zhang J; Zhang G; Zhang Y; Hao M; Zhang Z; Fan P; Dong Y; Yang Y; Chen Z; Guo Y; Zhang J; Li Y; Song X; Chen Y; Xia L; Fu L; Hou L; Xu J; Yu C; Li J; Zhou Q; Chen W Science; 2020 Aug; 369(6504):650-655. PubMed ID: 32571838 [TBL] [Abstract][Full Text] [Related]
24. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak. Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308 [TBL] [Abstract][Full Text] [Related]
25. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882 [TBL] [Abstract][Full Text] [Related]
26. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics? Bianchi M; Benvenuto D; Giovanetti M; Angeletti S; Ciccozzi M; Pascarella S Biomed Res Int; 2020; 2020():4389089. PubMed ID: 32596311 [TBL] [Abstract][Full Text] [Related]
27. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences. Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454 [TBL] [Abstract][Full Text] [Related]
28. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients. Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912 [TBL] [Abstract][Full Text] [Related]
29. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19. Xu W; Wang M; Yu D; Zhang X Front Immunol; 2020; 11():565278. PubMed ID: 33013929 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 and RT-PCR in asymptomatic patients: Results of a cohort of workers at El Dorado International Airport in Bogotá, 2020. Malagón-Rojas J; Gómez-Rendón C; Parra EL; Almentero J; Palma R; López R; Toloza-Pérez YG; Rubio V; Bedoya JF; López-Díaz F; Franco-Muñoz C; Reales-González J; Mercado-Reyes M Biomedica; 2020 Oct; 40(Supl. 2):166-172. PubMed ID: 33152200 [TBL] [Abstract][Full Text] [Related]
31. Genomic and serological detection of bat coronavirus from bats in the Philippines. Tsuda S; Watanabe S; Masangkay JS; Mizutani T; Alviola P; Ueda N; Iha K; Taniguchi S; Fujii H; Kato K; Horimoto T; Kyuwa S; Yoshikawa Y; Akashi H Arch Virol; 2012 Dec; 157(12):2349-55. PubMed ID: 22833101 [TBL] [Abstract][Full Text] [Related]
32. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein. Gao T; Gao Y; Liu X; Nie Z; Sun H; Lin K; Peng H; Wang S BMC Microbiol; 2021 Feb; 21(1):58. PubMed ID: 33618668 [TBL] [Abstract][Full Text] [Related]
33. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions. Sangith N Med Hypotheses; 2020 Nov; 144():110030. PubMed ID: 32758876 [TBL] [Abstract][Full Text] [Related]
34. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. Peng Y; Du N; Lei Y; Dorje S; Qi J; Luo T; Gao GF; Song H EMBO J; 2020 Oct; 39(20):e105938. PubMed ID: 32914439 [TBL] [Abstract][Full Text] [Related]
35. Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus. He R; Leeson A; Ballantine M; Andonov A; Baker L; Dobie F; Li Y; Bastien N; Feldmann H; Strocher U; Theriault S; Cutts T; Cao J; Booth TF; Plummer FA; Tyler S; Li X Virus Res; 2004 Oct; 105(2):121-5. PubMed ID: 15351485 [TBL] [Abstract][Full Text] [Related]
36. The coronavirus nucleocapsid protein is ADP-ribosylated. Grunewald ME; Fehr AR; Athmer J; Perlman S Virology; 2018 Apr; 517():62-68. PubMed ID: 29199039 [TBL] [Abstract][Full Text] [Related]
37. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Luo C; Luo H; Zheng S; Gui C; Yue L; Yu C; Sun T; He P; Chen J; Shen J; Luo X; Li Y; Liu H; Bai D; Shen J; Yang Y; Li F; Zuo J; Hilgenfeld R; Pei G; Chen K; Shen X; Jiang H Biochem Biophys Res Commun; 2004 Aug; 321(3):557-65. PubMed ID: 15358143 [TBL] [Abstract][Full Text] [Related]
38. Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection. Lake CM; Breen JJ Sci Rep; 2023 Jan; 13(1):389. PubMed ID: 36617594 [TBL] [Abstract][Full Text] [Related]